Pro12Ala Polymorphism of the PPARG2 Gene Is Associated with Type 2 Diabetes Mellitus and Peripheral Insulin Sensitivity in a Population with a High Intake of Oleic Acid 1

Desvergne, 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr Rev, 20, 649 Deeb, 1998, Pro12Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity, and lowered body mass index, Nat Genet, 20, 284, 10.1038/3099 Yen, 1997, Molecular scanning of the human peroxisome proliferator activated receptor gamma gene in diabetic Caucasians: identification of a Pro12Ala PPARgamma 2 missense mutation, Biochem Biophys Res Commun, 241, 270, 10.1006/bbrc.1997.7798 Altshuler, 2000, The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes, Nat Genet, 26, 76, 10.1038/79216 Frederiksen, 2002, Studies of the Pro12Ala Polymorphism of the PPAR-gamma gene in the Danish MONICA Cohort: Homozygosity of the Ala Allele Confers a Decreased Risk of the Insulin Resistance Syndrome, J Clin Endocrinol Metab, 87, 3989 Kadowaki, 2002, The role of PPAR gamma in high-fat diet-induced obesity and insulin resistance, J Diabetes Complications, 16, 41, 10.1016/S1056-8727(01)00206-9 Gonzalez Sanchez, 2002, Effect of the Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population, Eur J Endocrinol, 147, 495, 10.1530/eje.0.1470495 Miles, 2000, Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency, J Clin Invest, 105, 287, 10.1172/JCI8538 Ek, 1999, Homozygosity of the Pro12Ala variant of the peroxisome proliferator activated receptor 2 (PPAR- 2): divergent modulating effects on body mass index in obese and lean men of Caucasian origin, Diabetologia, 42, 892, 10.1007/s001250051243 Hegele, 2000, Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree, J Clin Endocrinol Metab, 85, 2014 Lindi, 2002, Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study, Diabetes, 51, 2581, 10.2337/diabetes.51.8.2581 Meirhaeghe, 2004, Impact of genetic variation of PPAR in humans, Mol Genet Metab, 83, 93, 10.1016/j.ymgme.2004.08.014 Mancini, 1999, Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes, Diabetes, 48, 1466, 10.2337/diabetes.48.7.1466 Oh, 2000, Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects, J Clin Endocrinol Metab, 85, 1801 Hsueh, 2001, Interactions between variants in the beta3- adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity, Diabetes Care, 24, 672, 10.2337/diacare.24.4.672 Luan, 2001, Evidence for gene-nutrient interaction at the PPAR gamma locus, Diabetes, 50, 686, 10.2337/diabetes.50.3.686 Stefan, 2001, Effects of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene, Diabetes, 50, 1143, 10.2337/diabetes.50.5.1143 Franks, 2004, Does peroxisome proliferator-activated receptor gamma genotype (Pro12Ala) modify the association of physical activity and dietary fat with fasting insulin level?, Metabolism, 53, 11, 10.1016/j.metabol.2003.08.005 Willett, 2002, Dietary fat plays a major role in obesity: no, Obes Rev, 3, 59, 10.1046/j.1467-789X.2002.00060.x Xu, 1999, Molecular recognition of fatty acids by peroxisome proliferator activated receptors, Mol Cell, 3, 397, 10.1016/S1097-2765(00)80467-0 Stumvoll, 2002, The peroxisome proliferator-activated receptor 2 Pro12Ala polymorphism, Diabetes, 51, 2341, 10.2337/diabetes.51.8.2341 Robitaille, 2003, The PPAR gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study, Clin Genet, 63, 109, 10.1034/j.1399-0004.2003.00026.x Memisoglu, 2003, Interaction between a peroxisome proliferator-activated receptor gene polymorphism and dietary fat intake in relation to body mass, Hum Mol Genet, 12, 2923, 10.1093/hmg/ddg318 Soriguer-Escofet, 2002, Prevalence of diabetes mellitus type LADA in South Spain, Diabetes Res Clin Pract, 56, 213, 10.1016/S0168-8227(02)00002-5 Soriguer, 2003, Hypertension is related to the degradation of dietary frying oils, Am J Clin Nutr, 78, 1092, 10.1093/ajcn/78.6.1092 1996, Junta de Andalucía, Sevilla Soriguer, 2003, Physical activity and cardiovascular and metabolic risk factors in general population, Med Clin (Barc), 121, 565, 10.1016/S0025-7753(03)74018-4 1995, World Health Organ Tech Rep Ser, 854, 1 Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Molarius, 1998, Selection of anthropometrics indicators for classification of abdominal fatness a critical review, Int J Obes Relat Metab Disord, 22, 719, 10.1038/sj.ijo.0800660 Soriguer, 1997, Lipid, protein and calorie content of different altlantic and mediterranean fish, shellfish and mollusks commonly eaten in the south of Spain, Eur J Epidemiol, 13, 451, 10.1023/A:1007327304925 Hamilton, 1992, Extraction of lipids and derivative formation, p13 1992 Matthews, 1985, Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Queipo-Ortuño, 1999, Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis, Biotechniques, 27, 248, 10.2144/99272bm06 Hara, 2000, The Pro12Ala Polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes, Biochem Biophys Res Commun, 271, 212, 10.1006/bbrc.2000.2605 Xu, 2002, Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error?, Hum Genet, 111, 573, 10.1007/s00439-002-0819-y Masud, 2003, Effect of the peroxisome proliferator activated receptor gene Pro12Ala variant on body mass index: a meta-analysis, J Med Genet, 40, 773, 10.1136/jmg.40.10.773 Douglas, 2001, The peroxisome proliferator activated receptor gamma Pro12Ala variant: association with type 2 diabetes and trait differences, Diabetes, 50, 886, 10.2337/diabetes.50.4.886 Mori, 2001, The Pro12 →Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes, Diabetes, 50, 891, 10.2337/diabetes.50.4.891 Walczak, 2002, PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism, J Lipid Res, 43, 177, 10.1016/S0022-2275(20)30159-0 Nicklas, 2001, Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain, Diabetes, 50, 2172, 10.2337/diabetes.50.9.2172 Kesteloot, 1992, Nutrition and international patterns of disease, p152 Serra-Majem, 2003, Ngo de la Cruz J, Ribas L, Tur JA. Olive oil and the Mediterranean diet: beyond the rhetoric, Eur J Clin Nutr, 57, S2, 10.1038/sj.ejcn.1601801 Rojo-Martínez, 2004, Patterns of insulin resistance in the general population of southeast Spain, Diabetes Res Clin Pract, 65, 247, 10.1016/j.diabres.2004.01.004